Robert H. Lemus

561 total citations
9 papers, 429 citations indexed

About

Robert H. Lemus is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Robert H. Lemus has authored 9 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 5 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Robert H. Lemus's work include Quinazolinone synthesis and applications (4 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and Synthesis of Indole Derivatives (2 papers). Robert H. Lemus is often cited by papers focused on Quinazolinone synthesis and applications (4 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and Synthesis of Indole Derivatives (2 papers). Robert H. Lemus collaborates with scholars based in United States. Robert H. Lemus's co-authors include Mark D. Erion, Edward B. Skibo, Paul D. van Poelje, Bheemarao G. Ugarkar, Michael C. Matelich, Timothy J. Colby, Jorge Gomez‐Galeno, K. Raja Reddy, Jürgen Schanzer and Serge H. Boyer and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Robert H. Lemus

9 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert H. Lemus United States 8 264 144 72 43 43 9 429
Gagan Kukreja India 12 401 1.5× 150 1.0× 44 0.6× 45 1.0× 33 0.8× 16 555
Jae-Taeg Hwang United States 13 330 1.3× 137 1.0× 35 0.5× 33 0.8× 19 0.4× 14 456
Bruno Haché Canada 9 365 1.4× 100 0.7× 51 0.7× 26 0.6× 13 0.3× 12 500
Michael A. Stier United States 15 378 1.4× 377 2.6× 50 0.7× 50 1.2× 26 0.6× 37 719
Suyeal Bae United States 12 381 1.4× 161 1.1× 49 0.7× 37 0.9× 19 0.4× 14 453
Donn G. Wishka United States 16 368 1.4× 186 1.3× 44 0.6× 31 0.7× 18 0.4× 38 671
Helen Y. Wu United States 12 262 1.0× 232 1.6× 65 0.9× 14 0.3× 8 0.2× 17 487
Hans Wallberg Sweden 12 247 0.9× 192 1.3× 119 1.7× 22 0.5× 16 0.4× 21 405
Robert F. Kaltenbach United States 14 357 1.4× 206 1.4× 80 1.1× 30 0.7× 11 0.3× 22 713
L B Townsend United States 9 228 0.9× 134 0.9× 30 0.4× 16 0.4× 15 0.3× 15 411

Countries citing papers authored by Robert H. Lemus

Since Specialization
Citations

This map shows the geographic impact of Robert H. Lemus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Lemus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Lemus more than expected).

Fields of papers citing papers by Robert H. Lemus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Lemus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Lemus. The network helps show where Robert H. Lemus may publish in the future.

Co-authorship network of co-authors of Robert H. Lemus

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Lemus. A scholar is included among the top collaborators of Robert H. Lemus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Lemus. Robert H. Lemus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Dang, Qun, Yan Liu, Daniel K. Cashion, et al.. (2010). Discovery of a Series of Phosphonic Acid-Containing Thiazoles and Orally Bioavailable Diamide Prodrugs That Lower Glucose in Diabetic Animals Through Inhibition of Fructose-1,6-Bisphosphatase. Journal of Medicinal Chemistry. 54(1). 153–165. 141 indexed citations
2.
Bookser, Brett C., Bheemarao G. Ugarkar, Michael C. Matelich, et al.. (2005). Adenosine Kinase Inhibitors. 6. Synthesis, Water Solubility, and Antinociceptive Activity of 5-Phenyl-7-(5-deoxy-β-d-ribofuranosyl)pyrrolo[2,3-d]pyrimidines Substituted at C4 with Glycinamides and Related Compounds. Journal of Medicinal Chemistry. 48(24). 7808–7820. 50 indexed citations
3.
Erion, Mark D., K. Raja Reddy, Serge H. Boyer, et al.. (2004). Design, Synthesis, and Characterization of a Series of Cytochrome P4503A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver§. Journal of the American Chemical Society. 126(16). 5154–5163. 126 indexed citations
4.
Skibo, Edward B., et al.. (2002). Pyrimidoquinazoline-Based Antitumor Agents. Design of Topoisomerase II to DNA Cross-linkers with Activity against Protein Kinases. Journal of Medicinal Chemistry. 45(25). 5543–5555. 28 indexed citations
5.
Nicolaou, K. C., Jonathan Groß, Michael A. Kerr, et al.. (1994). Synthese des Anthrachinongerüsts von Dynemicin A. Angewandte Chemie. 106(7). 790–791. 1 indexed citations
6.
Nicolaou, K. C., et al.. (1994). Synthesis of the Anthraquinone Framework of Dynemicin A. Angewandte Chemie International Edition in English. 33(7). 781–783. 47 indexed citations
8.
Lemus, Robert H., Chang‐Hee Lee, & Edward B. Skibo. (1989). Studies of extended quinone methides. Synthesis and physical studies of purine-like monofunctional and bifunctional imidazo[4,5-g]quinazoline reductive alkylating agents. The Journal of Organic Chemistry. 54(15). 3611–3618. 8 indexed citations
9.
Lemus, Robert H. & Edward B. Skibo. (1988). Studies of extended quinone methides. Design of reductive alkylating agents based on the quinazoline ring system. The Journal of Organic Chemistry. 53(26). 6099–6105. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026